2016
DOI: 10.1056/nejmoa1511014
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth

Abstract: Among girls and women with singleton pregnancies who had a short cervix, a cervical pessary did not result in a lower rate of spontaneous early preterm delivery than the rate with expectant management. (Funded by the Fetal Medicine Foundation; Current Controlled Trials number, ISRCTN01096902.).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
105
2
5

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 158 publications
(120 citation statements)
references
References 18 publications
8
105
2
5
Order By: Relevance
“…Six studies were assessed for eligibility. [3][4][5][6]12,13 Three trials including multiple pregnancies were excluded. [4][5][6] Three RCTs were therefore included in the meta-analysis.…”
Section: Study Selection and Study Characteristicsmentioning
confidence: 99%
See 2 more Smart Citations
“…Six studies were assessed for eligibility. [3][4][5][6]12,13 Three trials including multiple pregnancies were excluded. [4][5][6] Three RCTs were therefore included in the meta-analysis.…”
Section: Study Selection and Study Characteristicsmentioning
confidence: 99%
“…[4][5][6] Three RCTs were therefore included in the meta-analysis. 3,12,13 The overall risk of bias of the included trials was low ( Figure 2). All studies had a low risk of bias in "random sequence generation," "incomplete outcome data," and "selective reporting."…”
Section: Study Selection and Study Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…[56][57][58] In addition, one study compared 17-OHPC with cerclage 59 and three studies compared natural progesterone with 17-OHPC [60][61][62] (Table 1, and see Supporting information, Figure S2). …”
Section: Study Characteristicsmentioning
confidence: 99%
“…We will need more adaptive randomised trial Cervical cerclage remains the most popular first-line treatment choice, particularly in units without specialist preterm birth prevention services. This is likely to be the consequence of NICE guidance in combination with highprofile negative trials of vaginal progesterone 13 and the Arabin pessary 14 published in recent years.…”
Section: Discussionmentioning
confidence: 99%